CONMED (CNMD)
(Delayed Data from NYSE)
$73.32 USD
-2.93 (-3.84%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $73.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum B VGM
Cash flow Statements
Fiscal Year End for CONMED Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 64.46 | -80.58 | 62.54 | 9.52 | 28.62 |
Depreciation/Amortization & Depletion | 77.93 | 74.43 | 84.69 | 86.04 | 84.08 |
Net Change from Assets/Liabilities | -39.58 | -90.70 | -55.70 | -29.90 | -23.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 22.54 | 130.22 | 20.24 | -1.12 | 6.08 |
Net Cash From Operating Activities | 125.35 | 33.37 | 111.77 | 64.53 | 95.13 |
Property & Equipment | -19.03 | -21.79 | -14.87 | -13.01 | -20.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -227.74 | 0.00 | -3.85 | -367.60 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -1.00 | 0.00 | 0.00 | 3.23 | 0.00 |
Net Cash from Investing Activities | -20.03 | -249.53 | -14.87 | -13.64 | -387.66 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 72.00 | 0.00 | 0.00 | 30.57 |
Issuance (Repayment) of Debt | -88.00 | 260.65 | -81.24 | -26.25 | 311.65 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -24.50 | -23.96 | -23.26 | -22.82 | -22.60 |
Other Financing Activities | 2.07 | -83.69 | 2.95 | -2.99 | -18.74 |
Net Cash from Financing Activities | -110.43 | 225.00 | -101.55 | -52.06 | 300.88 |
Effect of Exchange Rate Changes | 0.47 | -0.74 | -1.87 | 2.67 | -0.01 |
Net Change In Cash & Equivalents | -4.65 | 8.10 | -6.51 | 1.50 | 8.35 |
Cash at Beginning of Period | 28.94 | 20.85 | 27.36 | 25.86 | 17.51 |
Cash at End of Period | 24.30 | 28.94 | 20.85 | 27.36 | 25.86 |
Diluted Net EPS | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 |
Fiscal Year End for CONMED Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 49.69 | 19.71 | 64.46 | 31.39 | 15.55 |
Depreciation/Amortization & Depletion | 38.69 | 19.45 | 77.93 | 58.43 | 39.01 |
Net Change from Assets/Liabilities | -17.05 | -11.59 | -39.58 | -45.26 | -47.08 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.10 | 1.56 | 22.54 | 24.39 | 15.34 |
Net Cash From Operating Activities | 72.43 | 29.12 | 125.35 | 68.95 | 22.83 |
Property & Equipment | -5.63 | -2.04 | -19.03 | -14.18 | -8.78 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -1.00 | -1.00 | -1.00 |
Net Cash from Investing Activities | -5.63 | -2.04 | -20.03 | -15.18 | -9.78 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -10.00 | 16.00 | -88.00 | -48.00 | -16.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -12.31 | -6.15 | -24.50 | -18.35 | -12.21 |
Other Financing Activities | -38.79 | -26.86 | 2.07 | 14.69 | 13.77 |
Net Cash from Financing Activities | -61.10 | -17.01 | -110.43 | -51.67 | -14.44 |
Effect of Exchange Rate Changes | -1.13 | -0.51 | 0.47 | -0.55 | 0.30 |
Net Change In Cash & Equivalents | 4.57 | 9.56 | -4.65 | 1.56 | -1.09 |
Cash at Beginning of Period | 24.30 | 24.30 | 28.94 | 28.94 | 28.94 |
Cash at End of Period | 28.87 | 33.86 | 24.30 | 30.50 | 27.85 |
Diluted Net EPS | 0.96 | 0.63 | 1.05 | 0.50 | 0.43 |